Memory Treatment Centers neurologist, Jamie Plante and current Leqembi patient were interviewed by the Wall Street Journal to investigate availability of new Alzheimers treatments. With the recent FDA approval of Leqembi (Lecanemab) in February 2023, Memory Treatment Centers has been…
Bonita Springs, FL February 6, 2023 – Last week, Memory Treatment Centers (MTC) became amongst the very first healthcare organizations within the United States to successfully begin administering Leqembi to qualified patients at its facilities. As a recently FDA-approved disease-modifying…
BONITA SPRING, FL, January 10, 2023 — Memory Treatment Centers are pleased to announce that the Food and Drug Administration (FDA) has approved Lecanemab, a new drug for the treatment of Alzheimer’s disease. This is an important milestone in the fight…
SALT LAKE CITY, Aug. 9, 2021 /PRNewswire/ — Memory Treatment Centers, a PURE Healthcare company (PURE), is excited to announce the completion of their first Aduhelm infusion. Memory Treatment Centers are among the first organizations to administer the new FDA approved Alzheimer’s drug,…
